Can you contrast Restasis versus Xiidra for chronic dry eye disease caused by aqueous tear deficiency and meibomian gland dropout?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
Can you contrast Restasis versus Xiidra for chronic dry eye disease caused by aqueous tear deficiency and meibomian gland dropout?
2 real searches · 1 real-search pass
Restasis cyclosporine ophthalmic emulsion prescribing information onset efficacy dry eye clinical trials Xiidra lifitegrast prescribing information onset symptoms signsGoogle ↗
OBSERVED
aqueous deficient dry eye cyclosporine versus lifitegrast comparative evidence meibomian gland dysfunction dropout treatment guidelineGoogle ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 2 queries…
Searches and sources
ChatGPT2 real searches · gpt-6
Restasis cyclosporine ophthalmic emulsion prescribing information onset efficacy dry eye clinical trials Xiidra lifitegrast prescribing information onset symptoms signs Google ↗
aqueous deficient dry eye cyclosporine versus lifitegrast comparative evidence meibomian gland dysfunction dropout treatment guideline Google ↗
- These highlights do not include all the information needed to use RESTASIS ® 0.05% safely and effectively. See full prescribing information for RESTASIS ® . RESTASIS ® ( cyclosporine ophthalmic emulsion ) 0.05% For topical ophthalmic use Initial U.S. Approval: 1983 · dailymed.nlm.nih.gov
- DailyMed · dailymed.awsprod.nlm.nih.gov
- Aqueous-deficient dry eye disease: Preferred practice pattern guidelines on clinical approach, diagnosis, and management · pmc.ncbi.nlm.nih.gov
- 2 INTRODUCTION · accessdata.fda.gov
- RESTASIS® (cyclosporine ophthalmic emulsion) 0.05% · dailymed.nlm.nih.gov
- Side Effects of Xiidra® (lifitegrast ophthalmic solution) 5% · xiidra-ecp.com
Queries
2 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
Restasis cyclosporine ophthalmic emulsion prescribing information onset efficacy dry eye clinical trials Xiidra lifitegrast prescribing information onset symptoms signs OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
aqueous deficient dry eye cyclosporine versus lifitegrast comparative evidence meibomian gland dysfunction dropout treatment guideline OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |